Caricamento...
Novel molecular targets of dezocine and their clinical implications
BACKGROUND: While dezocine is a partial mu opioid receptor agonist, it is not a controlled substance. Thus, the characterization of the molecular targets of dezocine is critical for scientific and clinical implications. The goal of this study is to characterize molecular targets for dezocine and the...
Salvato in:
| Autori principali: | , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2014
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3944410/ https://ncbi.nlm.nih.gov/pubmed/24263237 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/ALN.0000000000000076 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|